Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | NR1I3 | Q14994 | 11/20 | 0.59 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.59 |
| ▸ | AKT1 | P31749 | 3/20 | 0.59 |
| ▸ | AKT2 | P31751 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953862 | 0.92 | AKT1 (0.66) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL13599904 | 0.92 | AKT1 (0.66) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL5347018 | 0.89 | NPC1 (0.66) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL25790036 | 0.89 | NPC1 (0.56) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL22615103 | 0.88 | NPC1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL24479413 | 0.88 | AKT1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL22673557 | 0.88 | AKT1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL24479218 | 0.88 | AKT1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL22673697 | 0.88 | AKT1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 | |
| SCHEMBL24478955 | 0.88 | AKT1 (0.61) | NPC1RAB9ANR1I3NR1I2AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217820-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TELO2, SOD1, TERT | NPC1 3704/4885RAB9A 2202/4885NR1I3 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.